Sage Therapeutics, Inc. (NASDAQ:SAGE) Q3 2022 Earnings Call Transcript
Operator: Good morning. Welcome to the Sage Therapeutics' Third Quarter 2022 Financial Results Conference Call. Currently, all participants are in a listen-only mode.
Posts Tagged ‘NASDAQ:SAGE’
Hedge Fund and Insider Trading News: Steve Cohen, Dan Loeb, Sachem Head Capital Management, AIM Capital, Lions Gate Entertainment Corp. (LGF), Truist Financial Corp (TFC), and More
In the 18 months since billionaire hedge-fund manager Steve Cohen bought the New York Mets, the baseball world has wondered how the sport’s wealthiest owner would use his vast...
10 Market-Moving Stocks to Watch on Monday
Following April's tumultuous trading, investors are preparing themselves for more market-moving developments this week.
10 Best Healthcare Stocks To Buy In 2022
In this article, we discuss 10 best healthcare stocks to buy in 2022.
SAGE Therapeutics Inc (SAGE): Hedge Funds Are Taking Some Chips Off The Table
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quarter, which unveil their equity...
15 Biotech and Pharmaceutical Stocks to Buy According to Palo Alto Investors
In this article, we will take a look at 15 biotech and pharmaceutical stocks to buy according to Palo Alto Investors.
Should I Buy SAGE Therapeutics Inc (SAGE)?
Is SAGE Therapeutics Inc (NASDAQ:SAGE) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment...
Hedge Funds Aren’t Crazy About SAGE Therapeutics Inc (SAGE) Anymore
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Is SAGE Stock A Buy or Sell?
The Insider Monkey team has completed processing the quarterly 13F filings for the December quarter submitted by the hedge funds and other money managers included in our extensive...
Is SAGE A Good Stock To Buy According To Hedge Funds?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
SAGE Therapeutics Inc (SAGE): Hedge Funds In Wait-and-See Mode
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file ...
Did Hedge Funds Make The Right Call On SAGE Therapeutics Inc (SAGE) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Should You Avoid SAGE Therapeutics Inc (SAGE)?
In this article you are going to find out whether hedge funds think SAGE Therapeutics Inc (NASDAQ:SAGE) is a good investment right now.
Hedge Funds Were Buying SAGE Therapeutics Inc (SAGE) Before The Coronavirus
We hate to say this but, we told you so.
Hedge Fund Favorites vs. SAGE Therapeutics Inc (SAGE) In 2019
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019.
Hedge Fund and Insider Trading News: Ken Griffin, Ray Dalio, Brevan Howard Asset Management, Everett Capital Advisors, Cognex Corporation (CGNX), SAGE Therapeutics Inc (SAGE), and More
Brevan Howard Asset Management is again backing Adam Fisher, a global-macro manager whose capital-raising efforts appear to be rapidly gaining momentum.
Is SAGE Therapeutics Inc (SAGE) A Good Stock To Buy ?
Before we spend days researching a stock idea we like to take a look at how hedge funds and billionaire investors recently traded that stock.
Is SAGE Therapeutics Inc (SAGE) A Good Stock To Buy?
We at Insider Monkey have gone over 730 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio...
Is SAGE Therapeutics Inc (SAGE) A Good Stock To Buy?
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good.
Hedge Fund and Insider Trading News: Mike Novogratz, Ray Dalio, Daniel Loeb, AQR Capital, AGNC Investment Corp (AGNC), J B Hunt Transport Services Inc (JBHT), and More
Given the huge run-up in cryptocurrencies this year, billionaire investor Mike Novogratz is predicting Bitcoin will soon consolidate to a narrower trading range, but noted that...
Did Hedge Funds Drop The Ball On SAGE Therapeutics Inc (SAGE) ?
A whopping number of 13F filings filed with U.S.
Hedge Fund and Insider Trading News: Steve Cohen, Starboard Value LP, Restaurant Brands International Inc (QSR), Graco Inc. (GGG), and More
NEW YORK (Reuters) - Billionaire investor Steve Cohen’s Point72 Ventures has invested in a U.S.
Hedge Funds Are Selling SAGE Therapeutics Inc (SAGE)
A whopping number of 13F filings filed with U.S.
Three Biotech Investment Ideas from Cormorant Asset Management
The biotech industry is regaining ground it lost in 2016 at full speed.
Zogenix Inc. (ZGNX) and Arena Pharmaceuticals, Inc. (ARNA) Helped This Healthcare-Focused Fund Earn Double-Digit Returns
It's no secret that hedge funds have been underperforming the market by quite a wide margin in the last couple of years.
10 Biggest Antidepressant Drug Companies In 2017
The 10 biggest antidepressant drug companies in 2017 are committed to providing the safest and most cost-effective solution for consumers suffering from mental diseases worldwide...
Amid The Perceived Gloom In The Hedge Fund Universe, This Hedge Fund’s Stock Picks Gained 38.8% in Q1
The dismal performance, redemptions and shuttering of some hedge funds have received significant media attention in the past two years.
5 Stocks The Best Performing Hedge Funds Are Piling Into
At Insider Monkey, we track more than 700 of the best hedge funds in the world and have developed various market-beating strategies over the years using the wealth of data we ...
Positive Results For MDD Drug Sends Shares Of SAGE Therapeutics Inc (SAGE) Soaring
Shares of SAGE Therapeutics Inc (NASDAQ:SAGE) surged after the results of a small, mid-stage study on major depressive disorder showed positive results.
How SAGE Therapeutics Inc (SAGE) Stacks Up Against Its Peers
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
SAGE Therapeutics Inc (SAGE): What Just Happened, And What’s Next?
SAGE Therapeutics Inc (NASDAQ:SAGE) is running up on a trial update this week, with the company currently trading a little over 12% higher than its close on Friday.
Why Amazon, Starbucks and Three Other Stocks Are Trending Today
Among the newsworthy stocks amid the positive backdrop are Amazon.com, Inc.
Billionaire Ubben Buys More Shares of CBRE Group Inc. (CBG), Huber More Bullish on This Oil Tanker Stock, Plus Two Other Moves
Numerous sources and statistics recently indicated that hedge funds have been severely hit by the current volatile markets.
13G Filing: Visium Asset Management and Sage Therapeutics, Inc. (SAGE)
SAGE Therapeutics Inc (NASDAQ:SAGE) has recently been included in a filing by Jacob Gottlieb's Visium Asset Management.
The Smart Money Is Hoarding Shares of These 10 Healthcare Stocks: Part 1
Given elite hedge funds have filed their latest 13F's, we have an opportunity to analyze what hedge funds like and what they don't like.
Hedge Funds Are Selling SAGE Therapeutics Inc (SAGE)
Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to...
